Radient Pharmaceuticals Corporation fka RXPC

[Top Penny]

RXPC ~ Lung cancer is highly treatable in the early stages. Their test kit is superior in comparison to the competition. Onko-Sure is multifaceted, obviously test for more than just lung cancer. The distributors in the past did not do a good job of marketing Onko-Sure and way undershot in sales projections. Onko-Sure needs marketing and acceptance which in my opinion will come. RXPC fell victim to toxic financing. They are struggling as the share price projects. However, they have an FDA approved test kit that is anything but worthless. In my opinion they will merger. They should have merged in the past when Onko-Sure had no competition, prior to Doug coming aboard. Other companies put time and money into other products similar to Onko-Sure when they came out. Be interesting to see what transpires.

IMO